Clinical case series showed clinically meaningful reductions in wound size and pain, and improved tissue regranulation in ...

HealthEconomics.com interviews David W. Miller, CEO of Genesis Research Group, to discuss the unique challenges faced by ...

Cognition Therapeutics’ therapy showed up to a 129% slowing of cognitive decline in mild Alzheimer’s disease patients.

Black Box, a global leader in data center technologies, DAS, advanced networking, and AI, will host an exclusive one-day Executive Event in RTP on Tuesday, August 13. This event will feature thought ...

Media Release The pivotal TACTI-004 Phase III trial in first line non-small cell lung cancer (1L NSCLC) continues to build momentum and is recruiting patients at a growing number of activated clinical ...